Arrive AI secured its tenth U.S. patent on Monday for shared autonomous delivery endpoint technology. The news triggered a 32.39% spike in after-hours trading, pushing the stock to $0.89. During the regular session, ARAI had already gained 13.81%, closing at $0.67.
The new patent — No. 12,591,840 — covers multi-user functionality for Arrive AI’s “Arrive Points.” These are AI-powered secure receptacles that can accept deliveries from drones, ground robots, and human couriers. Multiple users can share a single unit, with built-in storage, sorting, and chain-of-custody controls.
CEO Dan O’Toole framed the technology around a gap in the autonomous delivery market. “Autonomous vehicles can move goods, but they cannot complete delivery at scale without a secure, intelligent endpoint,” he said.
Arrive AI doesn’t see itself as a rival to drone operators. Instead, it’s pitching itself as the infrastructure layer that makes those operators viable. Think of it like the plumbing behind the pipes — not the flashy part, but arguably the part that matters most.
Companies like Zipline and Alphabet’s Wing are already scaling drone delivery across the U.S. Arrive AI argues that without a standardized, secure handoff point, those networks can’t fully function at scale.
The company’s patent history goes back to 2017, when it filed foundational claims around autonomous delivery endpoints before many of today’s players entered the market.
The current portfolio covers drone and robotic docking systems, tamper-resistant delivery infrastructure, climate-controlled storage for sensitive goods, anti-theft systems, and integrated sensor networks.
Dozens of additional patents remain pending across more than 20 countries. O’Toole compared the company’s position to internet infrastructure: “Just as the internet required servers and cloud platforms, autonomous delivery requires a secure endpoint network. That’s what we are building — and protecting — with our patent portfolio.”
The healthcare logistics segment is one specific area Arrive AI has targeted, given the need for secure, time-sensitive delivery of medical supplies.
Despite the after-hours surge, ARAI’s broader price picture is rough. The stock has a market cap of just $22.87 million and has lost nearly 95% of its value over the past 12 months.
Its 52-week range runs from $0.51 to $40.00 — a wide band that tells its own story. The stock’s RSI sits at 33.30, putting it in oversold territory. It currently trades near the lower end of that range.
Benzinga’s Edge rankings show a negative price trend across all time frames for ARAI.
The after-hours move brings it back above the $0.89 mark, but the stock remains far from its highs.
The post Arrive AI (ARAI) Stock Pops 32% as Drone Delivery Patent Sparks Investor Interest appeared first on CoinCentral.
